Clinical Trials Insight: 700057617
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2010
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 13 Jul 2010 Status changed from not stated to completed.
- 13 Jul 2010 New trial record
- 25 Jun 2010 Results presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA 2010).